Literature DB >> 26472515

In vitro anti-HIV-1 activity of fucoidan from Sargassum swartzii.

Subramaniam Dinesh1, Thangam Menon2, Luke E Hanna3, V Suresh4, M Sathuvan5, M Manikannan6.   

Abstract

Sargassum swartzii, a marine brown algae with wide range of biological properties belongs to the family Sargassaceae. Bioactive fucoidan fractions (CFF, FF1 and FF2) were isolated from S. swartzii and characterized by linear gradient anion-exchange chromatography and FT-IR. The characterized fucoidan fractions contained mainly sugars, sulfate and uronic acid. In the present study, anti-HIV-1 property of the fucoidan fractions was investigated. Fraction FF2 was found to exhibit significant anti-HIV-1 activity at concentrations of 1.56 and 6.25 μg/ml as observed by >50% reduction in HIV-1 p24 antigen levels and reverse transcriptase activity. Fucoidan fractions have no cytotoxic effects on PBMCs at the concentration range of 1.56-1000 μg/ml. These results suggest that fucoidan fractions could have inhibitory activity against HIV and has potential as an anti-HIV-1 agent.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fucoidan; HIV-1; Reverse transcriptase; Sargassum swartzii

Mesh:

Substances:

Year:  2015        PMID: 26472515     DOI: 10.1016/j.ijbiomac.2015.09.078

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  28 in total

1.  Translational Research Symposium-collaborative efforts as driving forces of healthcare innovation.

Authors:  João Q Coentro; Andrea De Pieri; Diana Gaspar; Dimitrios Tsiapalis; Dimitrios I Zeugolis; Yves Bayon
Journal:  J Mater Sci Mater Med       Date:  2019-12-02       Impact factor: 3.896

2.  Properties of fucoidans beneficial to oral healthcare.

Authors:  Shunya Oka; Miku Okabe; Shuichi Tsubura; Masato Mikami; Akane Imai
Journal:  Odontology       Date:  2019-06-18       Impact factor: 2.634

Review 3.  Fucoidan from Marine Macroalgae: Biological Actions and Applications in Regenerative Medicine, Drug Delivery Systems and Food Industry.

Authors:  Grace Sathyanesan Anisha; Savitha Padmakumari; Anil Kumar Patel; Ashok Pandey; Reeta Rani Singhania
Journal:  Bioengineering (Basel)       Date:  2022-09-14

Review 4.  Antiviral Activity and Mechanisms of Seaweeds Bioactive Compounds on Enveloped Viruses-A Review.

Authors:  Silvia Lomartire; Ana M M Gonçalves
Journal:  Mar Drugs       Date:  2022-06-08       Impact factor: 6.085

5.  Anticancer Activity of Fucoidan via Apoptosis and Cell Cycle Arrest on Cholangiocarcinoma Cell.

Authors:  Pathanin Chantree; Kesara Na-Bangchang; Pongsakorn Martviset
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

6.  Synergistic Effects of Sulfated Polysaccharides from Mexican Seaweeds against Measles Virus.

Authors:  Karla Morán-Santibañez; Lucia Elizabeth Cruz-Suárez; Denis Ricque-Marie; Daniel Robledo; Yolanda Freile-Pelegrín; Mario A Peña-Hernández; Cristina Rodríguez-Padilla; Laura M Trejo-Avila
Journal:  Biomed Res Int       Date:  2016-06-22       Impact factor: 3.411

Review 7.  Fucoidans in Nanomedicine.

Authors:  Lucas Chollet; Pierre Saboural; Cédric Chauvierre; Jean-Noël Villemin; Didier Letourneur; Frédéric Chaubet
Journal:  Mar Drugs       Date:  2016-07-29       Impact factor: 5.118

Review 8.  Recent Advances in Marine Algae Polysaccharides: Isolation, Structure, and Activities.

Authors:  Shu-Ying Xu; Xuesong Huang; Kit-Leong Cheong
Journal:  Mar Drugs       Date:  2017-12-13       Impact factor: 5.118

Review 9.  Looking Beyond the Terrestrial: The Potential of Seaweed Derived Bioactives to Treat Non-Communicable Diseases.

Authors:  Kenneth G Collins; Gerald F Fitzgerald; Catherine Stanton; R Paul Ross
Journal:  Mar Drugs       Date:  2016-03-18       Impact factor: 5.118

10.  Investigation of Different Molecular Weight Fucoidan Fractions Derived from New Zealand Undaria pinnatifida in Combination with GroA Therapy in Prostate Cancer Cell Lines.

Authors:  Xu Yang; Sheng Wang; Sari Schokoroy Trangle; Yan Li; William Lindsey White; Jinyao Li; Tianlei Ying; Qingjun Kong; Yu Zhao; Jun Lu
Journal:  Mar Drugs       Date:  2018-11-18       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.